Response to crizotinib in a non-small-cell lung cancer patient harboring an EML4-ALK fusion with an atypical LTBP1 insertion

Fusion of the anaplastic lymphoma receptor tyrosine kinase gene (ALK) with the echinoderm microtubule-associated protein 4 gene (EML4) is the second most common actionable alteration in non-small-cell lung cancer, with a frequency of 5%. Here, we present a case of an EML4-ALK-positive patient with a...

पूर्ण विवरण

में बचाया:
ग्रंथसूची विवरण
में प्रकाशित:Onco Targets Ther
मुख्य लेखकों: Aguado, Cristina, Gil, Maria-de-los-Llanos, Yeste, Zaira, Giménez-Capitán, Ana, Teixidó, Cristina, Karachaliou, Niki, Viteri, Santiago, Rosell, Rafael, Molina-Vila, Miguel A
स्वरूप: Artigo
भाषा:Inglês
प्रकाशित: Dove Medical Press 2018
विषय:
Case Report
ऑनलाइन पहुंच:https://ncbi.nlm.nih.gov/pmc/articles/PMC5840185/
https://ncbi.nlm.nih.gov/pubmed/29535536
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OTT.S148363
टैग : टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!

समान संसाधन